Friday, May 27, 2022
  • Hype
  • Murai
  • Lipstiq
  • Diva
  • Varnam
  • Moviedash
  • Autofreaks
Lowyat.NET
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Hardware
      • Compu-zone
      • Viewnet
      • Thundermatch
      • Sri Computers
    • Notebooks
      • Compu-zone
    • Smartphones
      • Thundermatch
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables
No Result
View All Result
Lowyat.NET
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Hardware
      • Compu-zone
      • Viewnet
      • Thundermatch
      • Sri Computers
    • Notebooks
      • Compu-zone
    • Smartphones
      • Thundermatch
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables
No Result
View All Result
Lowyat.NET
No Result
View All Result
Home Coronavirus

Sinovac, Sinopharm Omicron Vaccine Approved For Clinical Trials

Both companies will still use the inactivated virus.

by Ikmal Rozlan
April 18, 2022
sinovac covid-19 vaccine vials

[Photo: COVID-19 vaccination/Flickr]

57
SHARES
Share on FacebookShare on Twitter

Sinovac and Sinopharm have both announced that their vaccine candidates that specifically target the Omicron variant of COVID-19 have been approved for clinical trials in Hong Kong. The candidates from the two companies both use inactivated coronavirus, similar to their current COVID-19 vaccine that is being used in several countries.

The Sinopharm candidates will be tested as boosters in adults who have already received two or three doses, while Sinovac said that it will conduct further studies on its existing vaccine’s protection against emerging variants. Studies have shown that the vaccines from both companies have rapidly waning efficacy.

Sinopharm covid-19 vaccine
[Photo: Ministerio de Defensa del Perú/Flickr]

Meanwhile, other COVID-19 vaccine manufacturers such as Moderna and Pfizer announced that they were working on an Omicron-specific vaccine shortly after the variant was discovered. Pfizer’s candidate was supposed to be ready by March but delayed due to “slower-than expected data gathering”, according to CEO Ugur Sahin.

ADVERTISEMENT

It is still too early to tell whether an Omicron-targeted vaccine will lead to Sinovac and Sinopharm being accepted by more countries. Some European countries still reject travellers who received either of the China-made shots for their primary series, leading to some Malaysians needing to get two Pfizer boosters in order to travel to countries such as Germany.

(Source: Reuters)

Tags: COVID-19omicronsinopharmSinovacvaccine
Back to top
Share23Tweet14SendShare

ADVERTISEMENT

RELATED ARTICLES

ktmb ets train
Transportation

KTMB Opens ETS, Intercity Ticket Sales For July Until December

by Ikmal Rozlan
May 27, 2022

KTMB has started selling tickets for ETS and Intercity service rides for the next six months. The company did the...

Read more
Samsung Teases 200MP ISOCELL Sensor With A Giant Cat Picture
Hardware

Samsung Teases 200MP ISOCELL Sensor With A Giant Cat Picture

by John Law
May 27, 2022

Last year, Samsung unveiled its 200MP ISOCELL mobile image sensor, dubbed the HP1. The new sensor had s apixel size...

Read more
Broadcom
Enterprise

Broadcom To Acquire VMware For US$61 Billion

by John Law
May 27, 2022

Broadcom announced that it will be acquiring the cloud computing and virtualisation technology firm, VMware, lock, stock, and barrel for...

Read more
AMD Confirms Socket AM5 CPUs Will Have 170W TDP, 230W Peak Power
Hardware

AMD Confirms Socket AM5 CPUs Will Have 170W TDP, 230W Peak Power

by John Law
May 27, 2022

Earlier in the week, AMD broke its silence on the Ryzen 7000 Series CPU and along with it, provided a...

Read more
Load More
No Result
View All Result

TRENDING TODAY

  1. 1
    Transportation

    Proposals For New Klang Valley Highways Approved To Reduce Congestion

  2. 2
    Mobile

    Samsung Galaxy A73 5G Review: Pushing The Price Barrier

  3. 3
    Fintech

    Enhanced TNG Card Sells Out Again Less Than Two Hours After Restock (UPDATE)

  4. 4
    Photography

    Huawei and Leica Partnership Is Officially Over

  5. 5
    Coronavirus

    Sinovac, Sinopharm Omicron Vaccine Approved For Clinical Trials

Lowyat.NET

Consumer Tech News & Reviews Malaysia

NETWORK

  • Hype
  • Murai
  • Lipstiq
  • Diva
  • Varnam
  • Moviedash
  • Autofreaks

ABOUT

  • Advertise
  • Careers
  • Privacy Statement
  • Contact Us
  • Editorial Policy
  • Terms & Conditions

©2022 LOWYAT MEDIA, LLC. ALL RIGHTS RESERVED.

No Result
View All Result
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Hardware
      • Compu-zone
      • Viewnet
      • Thundermatch
      • Sri Computers
    • Notebooks
      • Compu-zone
    • Smartphones
      • Thundermatch
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables

©2022 LOWYAT MEDIA, LLC. ALL RIGHTS RESERVED.

We use cookies to improve your experience. Learn More.